Sigma Planning Corp Has $331,000 Stock Holdings in SPDR S&P Biotech ETF $XBI

Sigma Planning Corp lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,090 shares of the exchange traded fund’s stock after selling 13,113 shares during the quarter. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $331,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $256,053,000. Bank of America Corp DE grew its position in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares during the last quarter. Wells Fargo & Company MN increased its holdings in SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after purchasing an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp increased its holdings in SPDR S&P Biotech ETF by 42,425.2% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares in the last quarter. Finally, Morgan Stanley raised its position in SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $165.37 on Thursday. The business’s fifty day moving average is $157.76 and its two-hundred day moving average is $140.05. The firm has a market cap of $10.80 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52 week low of $92.49 and a 52 week high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.